COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal ...
AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) — AiViva Biopharma Inc., ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...
The Institute for Science and Technology (IWT) has granted €250,000 to Novosanis, a company designs and develops medical devices for a variety of applications, in support of an SME innovation project ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する